Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Can G Leineweber,
Miriam Rabehl,
Anne Pietzner,
Nadine Rohwer,
Michael Rothe,
Maciej Pech,
Bruno Sangro,
Rohini Sharma,
Chris Verslype,
Bristi Basu,
Christian Sengel,
Jens Ricke,
Nils Helge Schebb,
Karsten-H Weylandt,
Julia Benckert
OAI: oai:www.repository.cam.ac.uk:1810/347674 • DOI: 10.17863/CAM.95089